Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nestle Sa Cham Et Ve (OP: NSRGF )

106.05 +0.05 (+0.05%)
Streaming Delayed Price Updated: 11:34 AM EDT, Jul 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,506
Open 104.35
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 106.00
Today's Range 104.35 - 106.05
52wk Range 95.73 - 125.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addressing regulatory concerns and focusing on marketing through social media. 
Via Benzinga
Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, and essential nutrients. Available Q4 nationwide. 
Via Benzinga

Performance

YTD
-7.87%
-7.87%
1 Month
+0.38%
+0.38%
3 Month
+3.11%
+3.11%
6 Month
-4.32%
-4.32%
1 Year
-11.85%
-11.85%

More News

Read More
Keurig Dr Pepper Reaffirms Its Guidance, Time to Buy?
Via MarketBeat
Magnificent 7 Stocks Become The Star Attractions For Norway's Sovereign Wealth Fund
Via Benzinga
Is My Candy Bar Getting Smaller? Yes, A Chocolate Crisis Means Smaller, Pricier Hershey's
Via Benzinga
Economic Armor: 7 Defensive Consumer Stocks to Weather Any Storm
Via InvestorPlace
Arm's IPO Could Be Valued At $54B, Google Slashes Jobs in Global Recruiting, Starbucks Founder And Former CEO To Leave: Today's Top Stories
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
'Shrinkflation' Shame!: French Supermarket Carrefour Targets PepsiCo, Unilever and Others By Issuing Price Alerts
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
Ron DeSantis Escapes Car Accident Unhurt En Route To Campaign Event, TikTok Takes On Twitter, Analysts Expect Nvidia's AI Revenues To Reach $300B In Five Years: Today's Top Stories
Via Benzinga
Nestle, Danone Price Rises To Put Them Under France's Inflation Scanner: Report
Via Benzinga
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
Via Benzinga
Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
Via Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
Via Benzinga
Consumers Should Be Ready For Further Price Increases, Nestle's Chief Executive Says
Via Benzinga
Nestle Bets €40M On Enterome's Preclinical Food Allergy, IBD Hopeful
Via Benzinga
Third Largest Player In Baby Formula Jumps In To Ease Shortage In US
Via Benzinga
Very Good Food Appoints Former Nestle Executive As Interim CEO
Via Benzinga
More Non-US Companies Restricted Services In Russia After US Counterparts
Via Benzinga
New Sources of Alternative Proteins Coming in 2022, as Plant-Based Producers Promote New Ideas
Via FinancialNewsMedia
Dada Nexus, Nestlé Expand Partnership To Boost Omni-Channel Growth
Via Benzinga
Nestlé Bets $525M On Seres Therapeutics Microbiome Drug For Infectious Diseases
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.